Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04527900 · ClinicalTrials.gov registry record · Phase 2
The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach
A Phase 2 study, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT04527900 is a Phase 2 study that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 2 participants.
The verdict
NCT04527900, a Phase 2 study, was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
A phase 2 study with the primary objective of testing treatment compliance of Upfront Intensity Modulated Proton Beam Therapy (IMPT) and Concurrent Chemotherapy (UPPROACH) for Post-operative Treatment in Loco-regionally Advanced Endometrial Cancer is non-inferior to the historic compliance rate of the chemoradiation arm of GOG 258 study
Interventions
- DRUG carboplatin and paclitaxel
- RADIATION pelvic IMPT (Intensity Modulated Proton Therapy)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2021-02-23 |
| Est. Completion | 2024-07-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04527900
The ClinicalTrials.gov registry entry for NCT04527900 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which carboplatin and paclitaxel is the first listed.
NCT04527900 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04527900 about?
NCT04527900 is a clinical study titled "The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach". A phase 2 study with the primary objective of testing treatment compliance of Upfront Intensity Modulated Proton Beam Therapy (IMPT) and Concurrent Chemotherapy (UPPROACH) for Post-operative Treatment in Loco-regionally Advanced Endometrial Cancer is non-inferior to the historic compliance rate of t...
What is the current status of trial NCT04527900?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2021-02-23. Estimated completion is 2024-07-02.
What interventions are being tested in trial NCT04527900?
The interventions under investigation include: carboplatin and paclitaxel (DRUG), pelvic IMPT (Intensity Modulated Proton Therapy) (RADIATION).
Who is sponsoring clinical trial NCT04527900?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.